Skip to Main content Skip to Navigation
Patents

Mcl-1 modulating compounds for cancer treatment

Document type :
Patents
Complete list of metadatas

https://www.hal.inserm.fr/inserm-02545394
Contributor : Elizabeth Bernardo <>
Submitted on : Friday, April 17, 2020 - 9:15:32 AM
Last modification on : Friday, June 19, 2020 - 1:42:02 AM

Identifiers

  • HAL Id : inserm-02545394, version 1

Collections

Citation

Laurent Poulain, Anne-Sophie Voisin-Chiret, Jana Sopkova de Oliveira Santos, Ronan Bureau, Grégory Burzicki, et al.. Mcl-1 modulating compounds for cancer treatment. United States, Patent n° : US 20170071921 A1. 2019. ⟨inserm-02545394⟩

Share

Metrics

Record views

16